HIV treatment bulletin

RSS Atom • ISSN 1472-4683 • Subscribe • About

Side effects

Previous page • Next page

• Reversibility of lipoatrophy in HIV patients 2 years after switching from a thymidine analogue to abacavir Lipodystrophy and metabolic complications - Side effects - 2 June 2004

• Diabetes and HIV and HCV; aging/HIV and diabetes Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 2 May 2004

• Eating grapefruit triggers statin-related rhabdomyolysis PK and drug interactions - Side effects - 2 May 2004

• FDA panel recommends approval of New-Fill Lipodystrophy and metabolic complications - Side effects - 2 May 2004

• Lipodystrophy regresses in three patients switched to atazanavir Lipodystrophy and metabolic complications - Side effects - 2 May 2004

• Race affects absorption and clearance of efavirenz Conference reports - PK and drug interactions - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Update on peripheral neuropathy in HIV-infection Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Smoking marijuana provides analgesic effect on HIV neuropathy Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Two D:A:D updates: cardiovascular risk from HAART, and predictors of hypertension and changes in blood pressure Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Low-dose rHGH maintains reductions in abdominal fat for 60 weeks Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Rosiglitazone shows no benefit for lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Importance of dietary management in treating lipid disorders: soy diets may offer comparable effect as statins Lipodystrophy and metabolic complications - Side effects - 3 February 2004

• Lower doses of d4T produce similar efficacy and reduced side effects Conference reports - Lipodystrophy and metabolic complications - Side effects - EACS 9 Warsaw 2003 - 1 December 2003

• Switching from efavirenz to nevirapine to avoid CNS side effects Antiretrovirals - Conference reports - Side effects - 1 December 2003

• Intrauterine exposure to efavirenz Conference reports - PMTCT and maternal health - Side effects - Women's health - EACS 9 Warsaw 2003 - 1 December 2003

• Increased risk of myocardial infarction associated with duration of protease inhibitor treatment Side effects - 1 December 2003

• Newer nucleoside analogues show fewer adverse effects Conference reports - Side effects - ICAAC 43rd Chicago 2003 - 1 November 2003

• Testosterone therapy prevents loss of lean body mass, improves mood and libido in HIV positive women and increases bone mineral density in HIV positive men Side effects - 1 October 2003

• Only time with HIV infection and not specific antiretroviral therapy is associated with decreased bone mineral density Side effects - 1 October 2003

• Rosiglitazone with insulin resistance Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003

• Uridine treatment for mitochondrial toxicity Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003

• Severe efavirenz psychotic events Conference reports - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003

• Uridine as a potential treatment for NRTI related mitochondrial toxicity Conference reports - PK and drug interactions - Side effects - Lipodystrophy Workshop (IWADRW) 5 Paris 2003 - 1 September 2003

• Long term exposure to nucleoside analogues and peripheral nerve function Conference reports - Side effects - IAS 2 Paris 2003 - 1 September 2003

• Step-wise intervention eases diarrhoea linked to PI nelfinavir (Viracept) therapy Antiretrovirals - Conference reports - Side effects - IAS 2 Paris 2003 - 1 September 2003

• Bone mineral metabolism and HIV-infection Side effects - 1 September 2003

• FDA says some follow-up drug studies are never started Side effects - 1 July 2003

• Lamotrigine shows some benefit for HIV-associated painful sensory neuropathies Side effects - 1 July 2003

• Women: sexual function and relationships Conference reports - Side effects - Women's health - BHIVA 9th Manchester 2003 - 1 June 2003

• High levels of gout may be linked to HAART Conference reports - Lipodystrophy and metabolic complications - Side effects - BHIVA 9th Manchester 2003 - 1 June 2003

• Tenofovir side effects Side effects - 1 June 2003

• HIV-positive patients sustain acute myocardial infarction at a young age and have a benign in-hospital course Side effects - 1 June 2003

• Cardiovascular and cerebrovascular events in patients treated for HIV infection Side effects - 1 June 2003

• Severe hepatotoxicity during ART: incidence, liver histology, and outcome Side effects - 1 June 2003

• Peripheral neuropathy in HIV disease: Lactate levels may help determine if nucleoside toxicity is a contributing factor Side effects - 1 June 2003

• Less diarrhoea and bioequivalence with the new nelfinavir 625mg tablet Antiretrovirals - Conference reports - PK and drug interactions - Side effects - PK Workshop 4th 2003 - 1 May 2003

• The potential for probenecid to have a serious interaction with HIV-1 protease inhibitors Conference reports - PK and drug interactions - Side effects - PK Workshop 4th 2003 - 1 May 2003

• Tenofovir and renal tubular dysfunction Conference reports - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Approaches to treatment of lipodystrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Surgery for buffalo hump shows variable results depending on method Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Other studies – nucleosides and switching to abacavir; importance of lipoatrophy and buffalo hump Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• HAART to HEART: cardiovascular risk in HIV Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Alendronate, vitamin D and calcium are safe and effective treatment for HIV-associated bone loss Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Bone loss and fat loss are closely related in HIV patients on HAART Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Pegylated interferon associated with eye disorders Conference reports - Hepatitis coinfection - Side effects - CROI 10 (Retrovirus) 2003 - 1 April 2003

• Efavirenz effects worse than reported, study says Side effects - 1 March 2003

• Protease inhibitors and cardiovascular outcomes in patients with HIV-1 Lipodystrophy and metabolic complications - Side effects - 1 March 2003

• HIV protease inhibitors promote atherosclerosis independent of dyslipidemia Lipodystrophy and metabolic complications - Side effects - 1 March 2003

• Comparison of the efficacy and safety of tenofovir vs. d4T when used in combination with 3TC and efavirenz in ARV-naive patients Antiretrovirals - Conference reports - Lipodystrophy and metabolic complications - Side effects - HIV 6 Glasgow 2003 - 1 February 2003

• Safety profile of tenofovir in treatment-experienced patients Antiretrovirals - Conference reports - Side effects - HIV 6 Glasgow 2003 - 1 February 2003

• Perspectives on hormonal, mitochondrial and metabolic changes Lipodystrophy and metabolic complications - Side effects - 1 December 2002

• IAS panel issues first guidelines for HIV and HIV drug-related metabolic complications Lipodystrophy and metabolic complications - Side effects - 1 December 2002

• Side effects are a common cause of intentional non adherence to HAART Side effects - 1 December 2002

• Adverse drug reactions and lipodystrophy in children Conference reports - Paediatric care - Side effects - ICAAC 42nd San Diego 2002 - 13 November 2002

• Lipodystrophy and adverse drug reaction data presented at the 42nd ICAAC Conference reports - Lipodystrophy and metabolic complications - Side effects - ICAAC 42nd San Diego 2002 - 13 November 2002

• A range of treatments for facial lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - Lipodystrophy Workshop (IWADRLH) 4 San Diego 2002 - 13 November 2002

• Tamoxifen for male breast enlargement? Lipodystrophy and metabolic complications - Side effects - 13 November 2002

• Diet can help reduce lipid levels in people with HAART-related dyslipemia Lipodystrophy and metabolic complications - Side effects - 13 November 2002

• Lipodystrophy syndrome and self-assessment of wellbeing and physical appearance in HIV-positive patients Lipodystrophy and metabolic complications - Side effects - 1 November 2002

• Abacavir hypersensitivity reactions in patients who rechallenge after interruptions for reasons other than hypersensitivity Conference reports - Side effects - World AIDS 14 Barcelona 2002 - 11 September 2002

• Prolonged CNS side-effects of efavirenz can be severe and lead to treatment discontinuation Conference reports - Side effects - 11 September 2002

• Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy Lipodystrophy and metabolic complications - Side effects - 11 September 2002

• Peripheral neuropathy: new data on risk factors, incidence and association with viral load Side effects - 11 September 2002

• High prevalence of osteonecrosis of the hip found in HIV-infection Side effects - 11 September 2002

• In switch study, women twice as likely as men to discontinue HAART due to toxicities Side effects - Women's health - 11 July 2002

• Neuropsychiatric complications of nevirapine treatment Side effects - 11 June 2002

• Paracardial fat in HIV-infected patient resembles pericardial effusion Lipodystrophy and metabolic complications - Side effects - 11 June 2002

• Altered adipocyte differentiation associated with protease inhibitors and lipoatrophy Lipodystrophy and metabolic complications - Side effects - 11 May 2002

• High mortality rate in patients with severe NRTI-associated lactic acidosis Side effects - 11 May 2002

• Tenofovir adversely affects development in foetal monkeys Side effects - 11 May 2002

• Tenofovir not toxic to mitochondria in human cell culture Side effects - 11 May 2002

• Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Switch to abacavir improves lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Potential use of niacin to reduce intra-abdominal fat Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Further benefits shown with New-Fill for facial atrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Lipodystrophy associated with lower CD4+ T cell counts Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Peripheral neuropathy update Conference reports - Side effects - CROI 9 (Retrovirus) 2002 - 10 April 2002

• Leptin reverses lipodystrophy in diabetic patients Lipodystrophy and metabolic complications - Side effects - 10 April 2002

• Meeting hears calls for NHS funding and training to provide repair treatment for people with facial lipoatrophy Lipodystrophy and metabolic complications - Side effects - Special reports - 10 March 2002

• Hepatic injury with nevirapine related to drug level and hepatitis C infection Antiretrovirals - Side effects - 10 March 2002

• It may be important to screen and treat riboflavin deficiency in patients on nucleoside analogues Antiretrovirals - Side effects - 10 March 2002

• Managing the metabolic side effects of antiretroviral therapy Lipodystrophy and metabolic complications - Side effects - 10 March 2002

• Intensive diet and exercise regimen may help fight lipodystrophy Lipodystrophy and metabolic complications - Side effects - 10 March 2002

• Avascular necrosis (AVN) may be increasingly common in HIV-positive patients Side effects - 10 March 2002

• Rheumatological complications associated with the use of indinavir and other protease inhibitors Side effects - 10 March 2002

• Doubt over use of antioxidant vitamins for the prevention of coronary disease Side effects - 10 January 2002

• Endocrine disorders complicate ARV treatment Lipodystrophy and metabolic complications - Side effects - 10 January 2002

• Enteric coated didanosine significantly reduces nausea, bloating, GI upset Antiretrovirals - Side effects - 9 December 2001

• Elevated blood pressure in subjects with lipodystrophy Side effects - 9 December 2001

• Fat distribution is strongly tied to metabolic disturbances in HIV lipodystrophy Lipodystrophy and metabolic complications - Side effects - 9 December 2001

• Eating more often can reduce cholesterol levels Lipodystrophy and metabolic complications - Side effects - 9 December 2001

• Further reports of benefits of polylactic acid for facial lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - EACS 8 Athens 2001 - 2 November 2001

• Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV cohort study Antiretrovirals - Side effects - 2 November 2001

• Preventable factors linked to indinavir-associated renal complications Side effects - 2 November 2001

• Nerve growth factor improves HIV-associated sensory neuropathy Opportunistic infections and complications - Side effects - 2 November 2001

• Lipodystrophy in HAART-treated patients may have multifactorial aetiology Lipodystrophy and metabolic complications - Side effects - 2 November 2001

• Rapidly ascending neuromuscular weakness associated with nucleoside analogues Side effects - Treatment alerts - 2 October 2001

• FDA requests changes in product information for all antiretrovirals Side effects - 1 October 2001

• Dihydrotestosterone for HAART-associated breast enlargement in men Lipodystrophy and metabolic complications - Side effects - 1 October 2001

• Osteopenia seen in testosterone-deficient women with AIDS wasting Lipodystrophy and metabolic complications - Side effects - Women's health - 1 October 2001

Previous page • Next page